Meng et al. uncovered that the loss of the E3 ubiquitin ligase CRL4 in ovarian cancer leads to slowed proliferation and the loss of chemotherapy resistance capabilities by upregulating mitophagy through the Parkin-PINK1 pathway [41]. This evidence concerns the gene PRKN and ovarian cancer.